Dofetilide: a new drug to control cardiac arrhythmia

Author： Elming Hanne Brendorp Bente Pedersen Ole Dyg Køber Lars Torp-Petersen Christian

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.6, 2003-06, pp. : 973-985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The hERG Channel and Risk of Drug-Acquired Cardiac Arrhythmia: An Overview

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-09 ,pp. : 1102-1112

Bentham Science Publishers

Access to resources Recommend Favorite

Dofetilide:

By Ward K.J. Gill J.S.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1269-1282

Informa Healthcare

Access to resources Recommend Favorite

Cardiac arrhythmia: in vivo screening in the zebrafish to overcome complexity in drug discovery

By MacRae Calum A

Expert Opinion on Drug Discovery, Vol. 5, Iss. 7, 2010-07 ,pp. : 619-632

Informa Healthcare

Access to resources Recommend Favorite

Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death: A Population-Based Case-Control Study in the Netherlands

By >

Drug Safety, Vol. 33, Iss. 11, 2010-11 ,pp. : 1003-1014

Adis International

Access to resources Recommend Favorite

Electrotherapy of cardiac arrhythmia – a success story

By Krämer Lars-Immo

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 321-325

Govi-Verlag

Access to resources Recommend Favorite